Impact of COVID-19 Lockdown on Glycemic, Weight, Blood Pressure Control and Medication Adherence in Patients with Type 2 Diabetes
- PMID: 37644964
- PMCID: PMC10461747
- DOI: 10.2147/PPA.S420545
Impact of COVID-19 Lockdown on Glycemic, Weight, Blood Pressure Control and Medication Adherence in Patients with Type 2 Diabetes
Abstract
Medication adherence profoundly affects blood glucose management in patients with type 2 diabetes. Measures to contain the COVID-19 pandemic have affected disease management and medication adherence, owing to limited access to healthcare facilities. This study aimed to examine the impact of the COVID-19 lockdown on adherence to glucose-lowering and lipid-lowering therapies (statins), and glycemic, weight, and systolic blood pressure control measures. A retrospective chart review was conducted one year pre- and post- March 18, 2020, for patients receiving glucose-lowering medications and lipid-lowering therapies (statins) in two major public hospitals in Malaysia. We compared the proportion of days covered by medication, HbA1c level, weight, and systolic blood pressure (SBP) values pre- and after the index date. A total of 1985 patients were included in this study. The adherence rate significantly increased for metformin, sulfonylureas dipeptidyl peptidase 4 inhibitors (DPP4i) and statin after the index date (metformin (PDC: 0.985 vs 0.978, p < 0.001), sulfonylureas (PDC: 0.988 vs 0.979, p < 0.01), DPP4i (PDC: 0.987 vs 0.98, p < 0.001), and statins (PDC: 0.983 vs 0.978, p < 0.05)). HbA1c levels were significantly reduced after the index follow-up (Mean difference: -0.43%, p < 0.001), while there was a 2.5 mmHg (p = 0.03) significant increase in SBP post-index follow-up. No significant changes in weight were observed during the post-index follow-up period. In this study, we observed better medication adherence and glycemic control among patients during the lockdown, but not for weight and systolic blood pressure control.
Keywords: SARS-CoV 2; adherence; covid-19; diabetes; glycemic; weight.
© 2023 Sim et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures




Similar articles
-
Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.J Manag Care Spec Pharm. 2016 Aug;22(8):892-900. doi: 10.18553/jmcp.2016.22.8.892. J Manag Care Spec Pharm. 2016. PMID: 27459651 Free PMC article.
-
Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas.Am Health Drug Benefits. 2017 Jun;10(4):165-174. Am Health Drug Benefits. 2017. PMID: 28794821 Free PMC article.
-
Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.J Manag Care Spec Pharm. 2014 Jul;20(7):691-700. doi: 10.18553/jmcp.2014.20.7.691. J Manag Care Spec Pharm. 2014. PMID: 24967522 Free PMC article.
-
Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review.Diabetol Metab Syndr. 2021 Sep 7;13(1):95. doi: 10.1186/s13098-021-00705-9. Diabetol Metab Syndr. 2021. PMID: 34493317 Free PMC article. Review.
-
Efficacy and safety of a sodium-glucose co-transporter-2 inhibitor versus placebo as an add-on therapy for people with type 2 diabetes inadequately treated with metformin and a dipeptidyl peptidase-4 inhibitor: a systematic review and meta-analysis of randomised controlled trials.Diabet Med. 2021 Feb;38(2):e14409. doi: 10.1111/dme.14409. Epub 2020 Nov 28. Diabet Med. 2021. PMID: 32979231
Cited by
-
Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland.Front Pharmacol. 2024 Apr 9;15:1350717. doi: 10.3389/fphar.2024.1350717. eCollection 2024. Front Pharmacol. 2024. PMID: 38655185 Free PMC article.
-
What is the impact of structural changes in society on diabetes self-management and trajectories of HbA1c? A cohort study before, during and after the COVID-19 pandemic in people with diabetes treated at outpatient clinics.PLoS One. 2025 Aug 12;20(8):e0329394. doi: 10.1371/journal.pone.0329394. eCollection 2025. PLoS One. 2025. PMID: 40794692 Free PMC article.
-
Hypertension in Adults With Diabetes in Southeast Asia: A Systematic Review.J Clin Hypertens (Greenwich). 2025 Jan;27(1):e14936. doi: 10.1111/jch.14936. Epub 2024 Nov 15. J Clin Hypertens (Greenwich). 2025. PMID: 39545715 Free PMC article.
References
-
- Federation ID. IDF Diabetes Atlas. 10th ed.; 2021.
-
- Expatriate Services Division. Covid-19 (latest announcement) [press release]. Immigration Department of Malaysia; 2020. Available from: https://esd.imi.gov.my/portal/latest-news/announcement/announcement-conv.... Accessed 17 June 2023.
LinkOut - more resources
Full Text Sources
Miscellaneous